High SUV39H1 expression was seen in tumors with wild-type IDH and older patients (Figure 9A) and increased with tumor grade, peaking in grade IV gliomas, which include GBM (P = 0.0248; Figure 9B). This evidence concerns the gene SUV39H1 and central nervous system cancer.